Machine learning model demonstrates stunting at birth and systemic inflammatory biomarkers as predictors of

Elizabeth Harrison1,2, Sana Syed3,4, Lubaina Ehsan1

  • 1School of Medicine, University of Virginia, Charlottesville, VA, USA.

BMC Pediatrics
|October 31, 2020
PubMed

Insights

Childhood stunting in LMICs often persists from birth to 48 months. Early height-for-age z-scores and inflammation biomarkers like CRP predict future growth, guiding interventions.

Area of Science:

  • Pediatrics
  • Global Health
  • Biostatistics

Background:

  • Childhood stunting is prevalent in low-to-middle income countries (LMICs), impacting cognitive development and vaccine response.
  • Early identification of at-risk infants is crucial for timely intervention and morbidity prevention.

Purpose of the Study:

  • To investigate growth patterns in infants up to 48 months of age.
  • To determine if stunting improves over time and identify predictors of growth.

Main Methods:

  • Longitudinal study tracking height-for-age z-scores (HAZ) at birth, 18, and 48 months in Pakistani infants.
  • Analysis of serum biomarkers (e.g., AGP, CRP, IL1) at 6 and 9 months.
  • Application of random forest models to predict growth outcomes.

Main Results:

  • Stunting prevalence remained high (51% at birth to 54% at 48 months).
  • Stunting status at 48 months often mirrored status at 18 months.
  • Height-for-age z-score at birth was the primary predictor of 18-month HAZ; AGP, CRP, and IL1 were significant biomarker predictors.

Conclusions:

  • Stunting in infancy frequently persists into early childhood.
  • Machine learning models effectively predict growth trajectories.
  • Early interventions targeting prenatal, birth, and early infancy periods are vital for at-risk populations in resource-constrained settings.
Abstract